Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Exponent, Inc. › Officer received an award of 2,970 EXPO derivative securities Insider trades
Why it stands out Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Mar 13, 2026
Reporting period Not applicable
Filed with the SEC Mar 16, 2026 Officer Grant / award
Context Classification grant award
Code A — grant or award
Planned / mechanical clue None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0000851520-26-000049
Filed / recorded
Mar 16, 2026, 8:20 PM UTC
Added to OQRO Oct 6, 2026, 7:37 PM UTC
Data quality Verified: identifiers matched exactly
Reporting person Richard Reiss
Officer title Group Vice President
Security Restricted Stock Units
Table Derivative (Table II)
Transaction date Mar 13, 2026
Acquired / disposed Acquired (A)
Footnotes from the filing 1-for-1. Not applicable.
Around the same time Insider filing
Traded Apr 6 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Apr 6 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider filing
Traded Mar 13 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jan 15, 2026 Insider CEO sold ~$121K of EXPO shares in the open market Feb 5, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors Feb 9, 2026 Federal contract · $58K obligated Department of Justice awarded EXPONENT INC: $58K obligated to date Feb 10, 2026 Insider · 1 person Insiders: 2 sales (~$304K) Feb 17, 2026 Insider · 1 person Insiders: 2 sales (~$263K) Mar 4, 2026 Federal contract · $327K obligated Department of Justice awarded EXPONENT INC: $327K obligated to date What came next Mar 16, 2026 Insider · 1 person Insiders: 2 sales (~$264K) Apr 6, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On April 6, 2026, Exponent, Inc.’s (the “Company”) board of directors (the “Board”) appointed Dr. Pye as its President, effective as of May 1, 2026. Dr. Pye, age 55, joined the Company in 1999.” Apr 15, 2026 Insider · 1 person Insiders: 2 sales (~$265K) Apr 30, 2026 Company filing · Form 8-K · Results, Reg FD Reported its results, and shared information with investors